Fabhalta APPULSE-PNH full results build on Phase III program, reporting new data from expanded PNH population in adults switching from anti-C5 Ianalumab Phase II data in immune thrombocytopenia and ...

• Applications are now being accepted, with $500,000 in grants to be awarded to projects focused on improving health equity in Canada Montreal, Quebec, May 14, 2025 – Novartis Pharmaceuticals Canada ...

Health disparities in Canada go beyond individual health issues - they underscore deeper societal injustices that undermine our social fabric. These inequities highlight the existence of systemic ...

While the exact reason for this gender imbalance remains unknown, researchers are exploring contributing factors, including hormones, environmental triggers, and antibody levels. 3 Nevertheless, the ...

Job Title Sort ascending Business Location Site Date Posted Praktikant Medical ab 112025 Early Career (Befristet), Full time Universal Hierarchy Node Germany Nuremberg (Non-Sales Force) (Novartis ...

Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.

To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.

The Reimagining Care Pathways CWP is a service offered by Novartis, which comprises a series of workshops, with the aim of providing pathway mapping support to the CW Partner to: Identify potential ...

The CWP aims to foster collaboration between Novartis Pharmaceuticals UK Limited and North West Anglia NHS Foundation Trust to enhance the multiple sclerosis service delivery for patients with ...

The company will make a total investment of $23B over the next five years, creating: Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities New ...

The Collaborative Working Project (“CWP”) aims to provide equity of access to NICE approved Systemic Anti-Cancer treatments (SACT) and maximise efficiency by optimising workforce capacity within the ...